Study on Analgesic Effect of Ultrasound-guided Quadratus Lumborum Block of Arcuate Ligament after kidney transplantation

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300072330

Enrollment

Unknown

Registered

2023-06-09

Start date

2022-08-18

Completion date

Unknown

Last updated

2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End stage renal disease

Interventions

Group N:ultrasound-guided quadratus lumborum block of lateral arcuate ligament

Group C:general anesthesia

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Gender unlimited; Age 18 ~ 65 years old; BMI 18 ~ 30kg / m2, ASA grade: II-IV; (2) Allogeneic kidney transplantation was performed for the first time; (3) Regular dialysis treatment before operation; (4) The family members of the patients voluntarily signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Accompanied by various active infections and abnormal functions of important organs (heart, liver, lung, etc.); (2) With autoimmune diseases (SLE, etc.); (3) Coagulation dysfunction; (4) Secondary renal transplantation; (5) Unable to cooperate with the researcher due to mental disorder or mental illness.

Design outcomes

Primary

Measure	Time frame
Intraoperative consumption of sufentanil;Intraoperative consumption of remifentanil;VAS scores at various postoperative time points;First request time for analgesic pump;	—

Secondary

Measure	Time frame
Creatinine;Urine volume;	—

Countries

China

Contacts

Public ContactDu Xueke

166 Daxue Road East, Nanning, Guangxi Zhuang Autonomous Region

46699644@qq.com+86 137 0788 0675

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026